E
EyePoint Pharmaceuticals D
D
EYPT
10.480
USD
-0.01
(-0.05%)
مغلق
حجم التداول
11,565
الربح لكل سهم
-3
العائد الربحي
-
P/E
-4
حجم السوق
721,146,993
الأخبار المقالات
العنوان: EyePoint Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.